U.S. MARKETS FOR INVASIVE AND NONINVASIVE DIAGNOSTIC CARDIOLOGY PRODUCTS

264 Pages | 66 Exhibits | 2014 Analysis | Forecasts Through 2018 Product Family: Market Reports




OVERVIEW:
In the next decade, the number of people living in the United States (U.S.) with diseases/disorders of the heart and vascular system is expected to continue to increase along with expansion in the elderly segment of the population and growth in the number of people with chronic conditions such as cardiovascular disease (CVD), diabetes, and obesity, which are exacerbated by unhealthful behaviors such as physical inactivity and tobacco smoking.

Diagnostic interventional cardiology procedures covered by the scope of this report include electrocardiography (ECG); non-invasive imaging systems including computed tomography (CT), magnetic resonance imaging (MRI), nuclear medicine, ultrasound, and X-ray; invasive diagnostic imaging systems including standard transcatheter coronary and peripheral angiography, electrophyiosology (EP) products, guidewire-based intravascular stenosis assessment, intracardiac echocardiography (ICE), intravascular ultrasound (IVUS), and optical coherence tomography (OCT); and in vitro diagnostics systems including cardiac markers, cholesterol testing products, and point-of-care/home coagulation monitoring systems. In the U.S. it is expected that the combined volume of these procedures will grow at a compound annual rate of 1.4% over the next half-decade, increasing from approximately 5.5 million in 2013 to an estimated 5.9 million in the year 2018. The total product sales for invasive and noninvasive diagnostic cardiology systems is expected to grow at a compound annual rate of 3.4% over the forecast period covered by this report, from approximately $3.8 billion in 2013 to an estimated $4.4 billion in the year 2018.

TABLE OF CONTENTS:
EXECUTIVE SUMMARY

i. Total Invasive and Noninvasive Diagnostic Cardiology Products Market
ii. Methodology

Exhibit ES-1: Invasive Diagnostic Cardiology Products Market, Share by Segment, 2013 and 2018
Exhibit ES-2: Noninvasive Diagnostic Cardiology Products Market, Share by Segment, 2013 and 2018

1. CARDIOVASCULAR DISEASE OVERVIEW

1.1 The Heart and Circulatory System
1.2 Selected Heart Diseases/Disorders
	1.2.1 Coronary Heart Disease
		1.2.1.1 Atherosclerosis
		1.2.1.2 Angina Pectoris
		1.2.1.3 Myocardial Infarction
	1.2.2 Hypertension
		1.2.2.1 Systolic and Diastolic Pressures
		1.2.2.2 Prehypertension
	1.2.3 Cardiomyopathy
		1.2.3.1 Dilated Cardiomyopathy
		1.2.3.2 Hypertrophic Cardiomyopathy
		1.2.3.3 Restrictive Cardiomyopathy
	1.2.4 Congenital Heart Defects
		1.2.4.1 Ventricular Septal Defects
		1.2.4.2 Atrial Septal Defects
		1.2.4.3 Patent Ductus Arteriosus
	1.2.5 Cardiac Rhythm Disorders
		1.2.5.1 Bradycardia
		1.2.5.2 Supraventricular Tachycardia
			1.2.5.2.1 Atrial Fibrillation
		1.2.5.3 Ventricular Tachycardia1
			1.2.5.3.1 Ventricular Fibrillation
	1.2.6 Heart Failure
		1.2.6.1 Disease Development
		1.2.6.2 Ejection Fraction Reduction
		1.2.6.3 Classification/Staging Systems
1.3 Peripheral Vascular Disease Overview
1.4 Anatomy and Physiology of the Circulatory System
1.5 Types of Peripheral Vascular Disease
	1.5.1 Peripheral Artery Disease
		1.5.1.1 Etiology
		1.5.1.2 Epidemiology
	1.5.2 Aneurysm
		1.5.2.1 Etiology
		1.5.2.2 Epidemiology
	1.5.3 Deep Vein Thrombosis and Pulmonary Embolism
		1.5.3.1 Etiology
		1.5.3.2 Epidemiology
	1.5.4 Chronic Venous Insufficiency
		1.5.4.1 Etiology
		1.5.4.2 Epidemiology
1.6 Cerebrovascular Disease Overview
	1.6.1 Stroke
		1.6.1.1 Etiology
		1.6.1.2 Epidemiology

Exhibit 1-1: Cross-Section Diagram of the Heart
Exhibit 1-2: Statistics for Selected Coronary Heart Disease Risk Factors
Exhibit 1-3: Standard Angina Pectoris Classification
Exhibit 1-4: Angina Pectoris, Selected Statistics
Exhibit 1-5: Clinical Classification of AMI
Exhibit 1-6: Myocardial Infarction, Selected Statistics
Exhibit 1-7: Percentage of Adults Who Have Been Told They Have High Blood Pressure, by State
Exhibit 1-8: Hypertension, Selected Statistics
Exhibit 1-9: Cardiomyopathy, Selected Statistics
Exhibit 1-10: Congenital Heart Defects, Selected Statistics
Exhibit 1-11: Summary, New York Heart Association Heart Failure Classification System
Exhibit 1-12: Summary, American College of Cardiology/American Heart Association  Heart Failure Staging System
Exhibit 1-13: Heart Failure, Selected Statistics
Exhibit 1-14: Peripheral Artery Disease, Facts and Figures
Exhibit 1-15: Aortic Aneurysm, Facts and Figures
Exhibit 1-16: Deep Vein Thrombosis, Facts and Figures
Exhibit 1-17: Classification of Chronic Venous Insufficiency
Exhibit 1-18: Chronic Venous Insufficiency, Facts and Figures
Exhibit 1-19: 2014, Stroke, Selected Statistics

2. NONINVASIVE DIAGNOSTIC CARDIOLOGY PROCEDURES AND PRODUCTS

2.1 Electrocardiography
	2.1.1 Resting Electrocardiography Examinations
	2.1.2 Exercise Stress Testing
	2.1.3 Ambulatory Electrocardiography
	2.1.4 Procedure Volumes
	2.1.5 Products
	2.1.6 Market Forecast
	2.1.7 Competitors
2.2 Conventional X-Ray Imaging
	2.2.1 Computed Radiography and Digital Radiography
	2.2.2 General Radiology/Fluoroscopy
	2.2.3 Cardiovascular X-Ray Systems
	2.2.4 Procedure Volumes
	2.2.5 Products
	2.2.6 Market Forecast
	2.2.7 Competitors
2.3 Computed Tomography
	2.3.1 Spiral Computed Tomography
	2.3.2 Multislice Computed Tomography
	2.3.3 Computed Tomography Angiography
	2.3.4 Perfusion Computed Tomography
	2.3.5 Cardiovascular-Related Applications of Computed Tomography
	2.3.6 Procedure Volumes
	2.3.7 Products
	2.3.8 Market Forecast
	2.3.9 Competitors
2.4 Magnetic Resonance Imaging
	2.4.1 Magnetic Resonance Angiography
		2.4.1.1 Contrast-Enhanced Magnetic Resonance Angiography
		2.4.1.2 Phase-Contrast Magnetic Resonance Angiography
		2.4.1.3 Time-of-Flight Magnetic Resonance Angiography
	2.4.2 Functional Magnetic Resonance Imaging
	2.4.3 Proton Magnetic Resonance Spectroscopy
	2.4.4 Interventional Magnetic Resonance
	2.4.5 Cardiovascular-Related Applications of Magnetic Resonance Imaging Techniques
	2.4.6 Procedure Volumes
	2.4.7 Products
	2.4.8 Market Forecast
	2.4.9 Competitors
2.5 Nuclear Medicine/Molecular Imaging
	2.5.1 Gamma Camera Imaging
	2.5.2 Positron Emission Tomography Scanner Imaging
	2.5.3 Fusion Imaging Techniques
	2.5.4 Cardiovascular-Related Applications of Nuclear Medicine Imaging
	2.5.5 Procedure Volumes
	2.5.6 Products
	2.5.7 Market Forecast
	2.5.8 Competitors
2.6 Diagnostic Ultrasound
	2.6.1 Doppler Imaging
	2.6.2 Duplex Ultrasonography
	2.6.3 Echocardiography
	2.6.4 Cardiovascular-Related Applications of Ultrasound Imaging
	2.6.5 Procedure Volumes
	2.6.6 Products
	2.6.7 Market Forecast
	2.6.8 Competitors
2.7 In Vitro Diagnostic Modalities
	2.7.1 Cholesterol Testing
	2.7.2 Cardiac Markers
		2.7.2.1 Creatine Kinase MB
		2.7.2.2 Myoglobin
		2.7.2.3 Cardiac Troponins
			2.7.2.3.1 Biochemical Markers in Point-of-Care Diagnostics of Heart Failure
	2.7.3 Coagulation Monitoring
		2.7.3.1 Activated Partial Thromboplastin Time Test
		2.7.3.2 Activated Clotting Time Test
		2.7.3.3 Bleeding Time Test
		2.7.3.4 Prothrombin Time Test
		2.7.3.5 Thrombin Clotting Time Test
	2.7.4 Procedure Volumes
	2.7.5 Products
	2.7.6 Market Forecast
	2.7.7 Competitors

Exhibit 2-1: Noninvasive Diagnostic Cardiology, Combined Procedure Volumes Forecast, 2013-2018
Exhibit 2-2: Diagnostic Cardiology Products, Combined Market Forecast, 2013-2018
Exhibit 2-3: Electrocardiography, Procedure Volumes Forecast, 2013-2018
Exhibit 2-4: Electrocardiography, Market Forecast, 2013-2018
Exhibit 2-5: 2013, Coronary Electrocardiography Devices Market, Share by Supplier
Exhibit 2-6: Coronary X-Ray, Procedure Volumes Forecast, 2013-2018
Exhibit 2-7: Cardiac X-Ray Systems, Market Forecast, 2013-2018
Exhibit 2-8: 2013, Cardiac X-Ray Devices Market, Share by Supplier
Exhibit 2-9: Computed Tomography, Procedure Volumes Forecast, 2013-2018
Exhibit 2-10: Computed Tomography Systems, Market Forecast, 2013-2018
Exhibit 2-11: 2013, Computed Tomography Devices Market, Share by Supplier
Exhibit 2-12: Magnetic Resonance Imaging, Procedure Volumes Forecast, 2013-2018
Exhibit 2-13: Magnetic Resonance Imaging Systems, Market Forecast, 2013-2018
Exhibit 2-14: 2013, Magnetic Resonance Imaging Devices Market, Share by Supplier
Exhibit 2-15: Nuclear Medicine Imaging, Procedure Volumes Forecast, 2013-2018
Exhibit 2-16: Nuclear Medicine Imaging Systems, Market Forecast, 2013-2018
Exhibit 2-17: 2013, Nuclear Medicine Imaging Devices Market, Share by Supplier
Exhibit 2-18: Diagnostic Ultrasound Imaging, Procedure Volumes Forecast, 2013-2018
Exhibit 2-19: Diagnostic Ultrasound Imaging Systems, Market Forecast, 2013-2018
Exhibit 2-20: 2013, Diagnostic Ultrasound Imaging Devices Market, Share by Supplier
Exhibit 2-21: In Vitro Diagnostic Testing, Procedure Volumes Forecast, 2013-2018
Exhibit 2-22: Cardiovascular In Vitro Diagnostic Testing, Market Forecast, 2013-2018
Exhibit 2-23: 2013, Cholesterol Testing Devices Market, Share by Supplier
Exhibit 2-24: 2013, Near-patient Cardiac Marker Testing Devices Market, Share by Supplier
Exhibit 2-25: 2013, Point-of-Care Coagulation Monitoring Devices Market, Share by Supplier

3. INVASIVE DIAGNOSTIC CARDIOLOGY PROCEDURES AND PRODUCTS

3.1 Angiography
	3.1.1 Coronary Angiography
	3.1.2 Peripheral Angiography
		3.1.2.1 Peripheral Arterial Angiography
		3.1.2.2 Peripheral Venous Agiography
	3.1.3 Procedure Volumes
	3.1.4 Products
	3.1.5 Market Forecast
	3.1.6 Competitors
3.2 Guidewire-Based Physiologic Intravascular Stenosis Assessment
	3.2.1 Technologies
	3.2.2 Procedure Volumes
	3.2.3 Products
	3.2.4 Market Forecast
	3.2.5 Competitors
3.3 Intracardiac Echocardiography
	3.3.1 Technologies
	3.3.2 Procedure Volumes
	3.3.3 Products
	3.3.4 Market Forecast
	3.3.5 Competitors
3.4 Intravascular Ultrasound
	3.4.1 Technologies
	3.4.2 Procedure Volumes
	3.4.3 Products
	3.4.4 Market Forecast
	3.4.5 Competitors
3.5 Optical Coherence Tomography
	3.5.1 Products
	3.5.2 Procedure Volumes
	3.5.3 Market Forecast
	3.5.4 Competitors
3.6 Electrophysiology
	3.6.1 Conventional Electrophysiology Studies
	3.6.2 Advanced Electrophysiology Mapping
	3.6.3 Products
	3.6.4 Procedure Volumes
	3.6.5 Market Forecast
	3.6.6 Competitors

Exhibit 3-1: Invasive Diagnostic Cardiology, Combined Procedure Volumes Forecast, 2013-2018
Exhibit 3-2: Invasive Diagnostic Cardiology Products, Combined Market Forecast, 2013-2018
Exhibit 3-3: Coronary and Peripheral Angiography, Procedure Volumes Forecast, 2013-2018
Exhibit 3-4: Coronary Angiography Devices, Market Forecast, 2013-2018
Exhibit 3-5: 2013, Coronary Angiography Devices Market, Share by Supplier
Exhibit 3-6: 2013, Peripheral Angiography Devices Market, Share by Supplier
Exhibit 3-7: Guidewire-Based Physiologic Intravascular Stenosis Assessment, Procedure Volumes Forecast, 2013-2018
Exhibit 3-8: Physiologic Intravascular Stenosis Assessment Guidewires, Market Forecast, 2013-2018
Exhibit 3-9: 2013, Physiologic Intravascular Stenosis Assessment Guidewire Systems Market, Share by Supplier
Exhibit 3-10: Intracardiac Echocardiography, Procedure Volumes Forecast, 2013-2018
Exhibit 3-11: Intracardiac Echocardiography Catheters, Market Forecast, 2013-2018
Exhibit 3-12: 2013, Intracardiac Echocardiography Catheters Market, Share by Supplier
Exhibit 3-13: Intravascular Ultrasound, Procedure Volumes Forecast, 2013-2018
Exhibit 3-14: Intravascular Ultrasound Products, Market Forecast, 2013-2018
Exhibit 3-15: 2013, Intravascular Ultrasound Products Market, Share by Supplier
Exhibit 3-16: Cardiovascular Optical Coherence Tomography, Procedure Volumes Forecast, 2013-2018
Exhibit 3-17: Cardiovascular Optical Coherence Tomography Systems, Market Forecast, 2013-2018
Exhibit 3-18: Electrophysiology, Procedure Volumes Forecast, 2013-2018
Exhibit 3-19: Electrophysiology Systems, Market Forecast, 2013-2018
Exhibit 3-20: 2013, Electrophysiology Products Market, Share by Supplier

APPENDIX:  COMPANY LISTING


COMPANIES COVERED:

  1. Abbott Laboratories
  2. Abbott Vascular/Abbott Laboratories
  3. AccuTech
  4. Agfa Healthcare
  5. Alere
  6. Analogic
  7. AngioDyanmics
  8. Arrow International, Inc./Teleflex, Inc.
  9. AtheroTech
  10. Aurora Imaging Technology
  11. B. Braun Melsungen AG
  12. Beckman Coulter
  13. bioMerieux
  14. Biosense Webster/Johnson & Johnson
  15. Boston Scientific Corporation
  16. Canon U.S.A./Canon
  17. Cardioline
  18. Chek Diagnostics
  19. Cook Medical/Cook Group, Inc.
  20. Cordis Corporation/ Johnson & Johnson
  21. Digirad
  22. Dilon Diagnostics
  23. Edan Instruments
  24. Esaote North America/Esaote
  25. Fukada Denshi U.S.A./Fukuda Denshi
  26. Gamma Medica
  27. General Electric Healthcare/General Electric Company
  28. Hitachi Medical Systems America/Hitachi
  29. International Technidyne
  30. IntraMedical Imaging
  31. Johnson & Johnson
  32. Konica Minolta U.S.A./Konica Minolta
  33. Medtronic, Inc.
  34. Merit Medical Systems, Inc.
  35. Mindray Medical International
  36. Mogul Enterprises
  37. Mortara Instruments
  38. Nihon Kohden
  39. Omega Medical Imaging
  40. Omron Healthcare/Omron
  41. Ortho Clinical Diagnostics/The Carlyle Group
  42. Positron Corporation
  43. QRS Diagnostic
  44. Response BioMedical
  45. Royal Philips Healthcare/Royal Philips
  46. Samsung Medison/Samsung
  47. Schiller America/Schiller AG
  48. Shimadzu Medical Systems/Shimadzu Corporation
  49. Siemens AG
  50. Siemens Healthcare/Siemens AG
  51. SonoSite/Fujifilm
  52. St. Jude Medical, Inc.
  53. Terason/Teratech Corporation
  54. Terumo Interventional Systems/Terumo Corporation
  55. Toshiba America Medical Systems/Toshiba Corporation
  56. TriFoil Imaging
  57. TZ Medical
  58. Varian Medical Systems
  59. Viztek
  60. Volcano Corporation
  61. Welch Allyn
Contact Us

Need help finding medtech research? Let us help you!